Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
People treated for hepatitis C have unexpectedly high rate of liver cancer recurrence

Hepatitis C patients with cirrhosis who were treated with direct-acting antivirals had about twice the expected likelihood of developing hepatocellular carcinoma (HCC), with the excess risk seen

Published
10 hours ago
By
Liz Highleyman
Portugal's roll-out of HCV therapy with DAAs achieves impressive results

Roll-out of hepatitis C virus (HCV) therapy using direct acting antivirals (DAAs) has achieved excellent outcomes in Portugal, data presented to the International Liver Congress in Barcelona shows.

Published
27 April 2016
By
Michael Carter
New York Insurers to Change Coverage of Hepatitis C Drugs

Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

Published
26 April 2016
From
Wall Street Journal
Hepatitis C linked to increased risk of head, neck cancers, study suggests

People with hepatitis C may have at least twice the risk of developing certain head and neck cancers as individuals who don’t carry the virus, a U.S. study suggests.

Published
26 April 2016
From
The Globe and Mail
AIDS expert to head $5-million research efforts on hepatitis C

Health Minister Terry Lake on Thursday announced a $5-million study that will look at how to reduce the spread of hepatitis C among intravenous drug users, sex workers and men who have sex with men. It will concentrate on people who have already taken medication that clears them of the hepatitis C virus, but who could be reinfected if they have blood-to-blood contact with another person. They will be encouraged to prevent that by using condoms, not sharing needles and taking part in support programs through Vancouver Coastal Health, one of the five organizations involved in the program.

Published
22 April 2016
From
Vancouver Sun
Interferon-based therapy improves clinical outcomes in hepatitis delta infection

Patients with hepatitis delta virus infection treated with pegylated interferon alpha were less likely to develop clinical outcomes — like decompensation or hepatocellular carcinoma — compared with patients who received nucleos(t)ide based treatment or no treatment at all, according to a presentation at International Liver Congress.

Published
22 April 2016
From
Healio
DAAs achieve excellent outcomes in real-world settings

Hepatitis C virus (HCV) therapy with direct acting antivirals (DAAs) is as effective in real-world settings as it was in clinical trials, according to US research presented

Published
21 April 2016
By
Michael Carter
High incidence of HCV re-infection among HIV-positive MSM in Western Europe

There is a very high incidence of hepatitis C virus (HCV) re-infection among HIV-positive men who have sex with men (MSM) in western Europe, according to research

Published
19 April 2016
By
Michael Carter
Sofosbuvir/velpatasvir cures HCV in 95% of people with HCV and HIV co-infection

A dual regimen of sofosbuvir plus velpatasvir was well tolerated and highly effective against hepatitis C virus (HCV) genotypes 1 through 4 in HIV-positive people with chronic

Published
19 April 2016
By
Liz Highleyman
Hepatitis C: no more treatment rationing; universal access to generic medicines everywhere!

People with hepatitis C virus (HCV) and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. They are pushing for generic competition to bring down the price of HCV treatment and ensure universal access.

Published
18 April 2016
From
Treatment Action Group
← First12345...196Next →

Filter by country